Braun Stacey Associates’s Exelixis EXEL Stock Holding History

Braun Stacey Associates’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-434,099	Closed	-$10.4M	–	114
2023 Q4	$10.4M	Buy	+434,099	New	+$9.44M	0.47%	82

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Braun Stacey Associates's EXEL Position: Q1 2024 in Review

Braun Stacey Associates sold out of Exelixis (EXEL) in Q1 2024, closing a stake of 434,099 shares — an estimated $10.4M sold.

Braun Stacey Associates first reported a position in EXEL in Q4 2023 and held it in 1 quarter. The position peaked at $10.4M in Q4 2023. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

Braun Stacey Associates reported no remaining Exelixis position as of Q1 2024 after selling out during the quarter.
Braun Stacey Associates sold 434,099 Exelixis shares in Q1 2024, an estimated $10.4M.
Braun Stacey Associates first reported a position in Exelixis in Q4 2023 and held it in 1 quarter.
Braun Stacey Associates's Exelixis position peaked at $10.4M in Q4 2023.
422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Braun Stacey Associates's 13F filing for Q1 2024, filed 30 Apr 2024.